InsiderTrades

Form 4 for IMAX IMAX CORP

Accepted 2023-03-13 00:00:00 ET · period of report 2023-03-07 · accession 0001214659-23-003796 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-13 2023-03-07 IMAX LISTER ROBERT D Chief Legal, Sr EVP M - OptEx $0.00 +69.0K 161.8K +74% $0
DM 2023-03-13 2023-03-07 IMAX LISTER ROBERT D Chief Legal, Sr EVP F - Tax $18.43 -52.0K 134.6K -28% -$957.5K
D 2023-03-13 2023-03-07 IMAX LISTER ROBERT D Chief Legal, Sr EVP A - Grant $0.00 +24.8K 148.4K +20% $0
D 2023-03-13 2023-03-07 IMAX LISTER ROBERT D Chief Legal, Sr EVP A - Grant $0.00 +38.9K 38.9K New $0
DM 2023-03-13 2023-03-07 IMAX LISTER ROBERT D Chief Legal, Sr EVP M - OptEx $0.00 -69.0K 14.7K -82% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common common shares 2023-03-07 M A 23,586 $0.00 128,064 D — — (F1) Represents the conversion upon vesting of restricted share units into common shares.
2 Common common shares 2023-03-07 M A 7,055 $0.00 135,119 D — — (F1) Represents the conversion upon vesting of restricted share units into common shares.
3 Common common shares 2023-03-07 M A 14,733 $0.00 149,852 D — — (F1) Represents the conversion upon vesting of restricted share units into common shares.
4 Common common shares 2023-03-07 F D 38,163 $18.43 123,646 D — — (F2) Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
5 Common common shares 2023-03-07 A A 24,764 $0.00 148,410 D — — (F3) Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2020. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
6 Common common shares 2023-03-07 F D 13,792 $18.43 134,618 D — — (F4) Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.
7 Common common shares 2023-03-07 M A 11,674 $0.00 104,478 D — — (F1) Represents the conversion upon vesting of restricted share units into common shares.
8 Common common shares 2023-03-07 M A 11,957 $0.00 161,809 D — — (F1) Represents the conversion upon vesting of restricted share units into common shares.
9 Derivative restricted share units 2023-03-07 A A 38,873 $0.00 38,873 D $0.00 · — to — 38,873 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F12) The restricted share units vest and will be converted to common shares in three installments: 12,957 on each of March 7, 2024 and March 7, 2025 and 13,406 March 7, 2026.
10 Derivative restricted share units 2023-03-07 M D 11,957 $0.00 23,916 D $0.00 · — to — 11,957 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F11) The restricted share units vest and will be converted to common shares in three installments: 11,957 on each of March 7, 2023 and March 7, 2024 and 11,959 on March 7, 2025.
11 Derivative restricted share units 2023-03-07 M D 7,055 $0.00 0 D $0.00 · — to — 7,055 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F9) The restricted share units vest and will be converted to common shares in two equal installments on each of the first two anniversaries of the grant date.
12 Derivative restricted share units 2023-03-07 M D 23,586 $0.00 0 D $0.00 · — to — 23,586 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F8) The restricted share units vest and will be converted to common shares in three installments: 23,584 on each of March 7, 2021 and March 7, 2022 and 23,586 on March 7, 2023.
13 Derivative restricted share units 2023-03-07 M D 11,674 $0.00 0 D $0.00 · — to — 11,674 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F7) The restricted share units vest and will be converted to common shares in four installments: 11,671 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 11,674 on March 7, 2023.
14 Derivative restricted share units 2023-03-07 M D 14,733 $0.00 14,733 D $0.00 · — to — 14,733 common shares (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F13) This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F10) The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.